Patient-Derived Mutant Forms of NFE2L2/NRF2 Drive Aggressive Murine Hepatoblastomas
H. Wang, J. Lu, J. A. Mandel, W. Zhang, M. Schwalbe, J. Gorka, Y. Liu, B. Marburger, J. Wang, S. Ranganathan, E. V. Prochownik
This study shows that patient-derived NFE2L2 mutants drive aggressive hepatoblastomas in mice by accelerating tumor growth and promoting necrosis and cyst formation.
bioRxiv · Sep 13, 2020Cancer Biology